TU

Triono Untung Piryadi

Director Director DIN 06513509
DIN 06513509 First appointment Dec 2012 Primary industry Musical Instruments
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2012
Shareholding value •••• Premium profile

About Triono Untung Piryadi

Data last updated:

Triono Untung Piryadi was a Director at Pine Biotech Private Limited (2012–2020) and Director at Lsj Biotech Private Limited (2012–2020). The companies operate in Musical Instruments.

DIN 06513509
Primary Designation Director
Industry Musical Instruments
First Appointment 27 Dec 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pine Biotech Private Limited U15132AS2012PTC011153
Director27 Dec 20122012Active
Lsj Biotech Private Limited U15490AS2012PTC011179
Director27 Dec 20122012₹4.15 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pine Biotech Private Limited
Lsj Biotech Private Limited
Premium access

Shareholding and investment profile for Triono Untung Piryadi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Triono Untung Piryadi

Triono Untung Piryadi was first appointed on 27 Dec 2012 as Director at Pine Biotech Private Limited.

Triono Untung Piryadi held 2 earlier board appointments: Pine Biotech Private Limited (Director, 27 Dec 2012 to 23 Nov 2020); Lsj Biotech Private Limited (Director, 27 Dec 2012 to 23 Nov 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available